Major changes in diagnosis and management of preeclampsia

Journal of Midwifery and Women's Health

Volumn 59, Issue 6, 2014, Pages 596-605

  Snydal, Susan ^a  

^a American College of Nurse Midwives   (United States)

Author keywords

Eclampsia; Gestational hypertension; Maternal mortality; Postpartum; Preeclampsia; Pregnancy; Pregnancy induced hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CREATININE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; PLACEBO;

ANESTHESIA INDUCTION; BLOOD PRESSURE MEASUREMENT; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PRACTICE; CONTROLLED CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; DELAYED DIAGNOSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; GESTATIONAL AGE; HEADACHE; HUMAN; KIDNEY DISEASE; LABOR INDUCTION; LIVER DISEASE; LIVER FUNCTION TEST; LOW DRUG DOSE; MATERNAL CARE; MATERNAL HYPERTENSION; MEDICAL TERMINOLOGY; NONHUMAN; PLACENTA FUNCTION; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; BLOOD PRESSURE; FEMALE; HYPERTENSION; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREGNANCY;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA;

EID: 84927560982     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/jmwh.12260     Document Type: Review

References (55)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-137.
2. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia and gestational hypertension, United States, 1987-2004. Am J Hypertension. 2008;21(5):521-526.
3. The California Pregnancy-Associated Mortality Review. Report from 2002 and 2003 Maternal Death Reviews. Sacramento, CA: California Department of Public Health, Maternal Child and Adolescent Health Division; 2011.
4. Cantwell R, Clutton-Brock T, Cooper G, et al. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl. 1):1-203.
5. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol. 2009;200:481.e1-e7.
6. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labor versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicenter, open-label randomized controlled trial. Lancet. 2009;374:979-988.
7. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.
8. The GRADE working group. Available at: www.gradeworkinggroup.org/index.htm. 2005-2014. Accessed June 25, 2014.
9. James, JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol. 2010;221:363-378.
10. Steegers EAP, von Dadelszen P, Duvikot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
11. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009; 30:S32-S37.
12. Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(Suppl. A):S38-S42.
13. Young BC, Levine RJ, Kurumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis. 2010;5:173-192.
14. Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction. 2011;141:715-724.
15. Bauer ST, Cleary KL. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol. 2009;33:158-165.
16. Kamumanchi SA, Stilman I, Lindheimer MD. Angiogenesis and preeclampsia. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego, CA: Academic Press; 2009.
17. Mirza FG, Cleary KL. Pre-eclampsia and the kidney. Semin Perinatol. 2009;33:173-178.
18. Grand'Maison S, Sauve N, Weber F, Dagenais M, Durand M, Mahone M. Hepatic rupture in hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 2012;119:617-625.
19. Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009;33:166-172.
20. van Veen TR, Panerai RB, Haeri S, Griffioen AC, Zeeman GG, Belfort MA. Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol. 2013;122:1064-9.
21. Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead, CL. Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol. 2011;118:995-9.
22. Hall DR. Abruptio placentae and disseminated intravascular coagulopathy. Semin Perinatol. 2009;33: 189-195.
23. Martin JN, Thigpen BD, Moore DO, Rose CH, Cushman J, May W. Stroke and severe pre-eclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105(2):246-254.
24. American College of Obstetricians and Gynecologists. Committee Opinion Number 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol. 2011;118:1465-1468.
25. Druzin ML, Shields LE, Peterson NL, Melsop K, Cape V. Preeclampsia Toolkit: Improving Health Care Response to Preeclampsia (California Maternal Quality Care Toolkit to Transform Maternity Care). Developed under contract #11-1006 with the California Department of Public Health; Maternal, Child and Adolescent Division. Published by the California Maternal Quality Care Collaborative; 2013. Updated January 2014. Available at: https://www.cmqcc.org/preeclampsia_toolkit. Accessed January 22, 2014.
26. Waugh J, Bell SC, Kilby MD, Lambert P, Shennan A, Halligan A. Urine protein estimation in hypertensive pregnancy: which thresholds and laboratory assay best predict clinical outcome? Hypertens Pregnancy. 2005;24:291-302.
27. Thangaratinam S, Coomarasamy A, O'Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10. doi:10.1186/1741-7015-7-10.
28. Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466-470.
29. Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol. 2010;115(2, part 1):365-375.
30. Cote AM, Firoz T, Mattman A, Lam E, von Dadelszen P, Magee LA. The 24-hour urine collection: gold standard or historical practice? Am J Obstet Gynecol. 2008;199:625.e1-e6.
31. Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ. 2012;345:e4342. doi: 10.1136/bmj.e4342.
32. Waugh JJS, Clark TJ, Divakaran TG, Khan KS, Kilby MD. Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol. 2004;103(4):769-777.
33. Thangaratinam S, Gallos ID, Meah N, Usman S, Ismail KMK, Khan KS. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90:564-573.
34. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24:104(2):104-110.
35. North RA, McCowan LM, Dekker GA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 2011;342:d1875.
36. Duley L, Henderson-Smart DJ, Meher S, Ling JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659. DOI:10.1002/14651858.CD004659.pub2.
37. von Dadelszen P, Payne B, Li J, Ansermino M, Pipkin FB, Cote, A, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377: 219-227.
38. Levine RJ, Hauth JC, Curet LB, Sibai BN, Catalano PM, Morris, CD. Trial of calcium to prevent preeclampsia. N Engl J Med. 1997;337:69-76.
39. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059. doi: 10.1002/14651858.CD001059.pub3.
40. World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva, Switzerland: World Health Organization; 2011.
41. You WB, Wolf M, Bailey SC, et al. Factors associated with patient understanding of pre-eclampsia. Hypertens Pregnancy. 2012; 31:341-349.
42. You, WB, Wolf, MS, Bailey SC, Grobman WA. Improving patient understanding of preeclampsia: a randomized controlled trial. Am J Obstet Gynecol. 2012;206:431.e1-e5.
43. Magee LA, von Dadelszen P. The management of severe hypertension. Semin Perinatol. 2009;33:138-142.
44. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Women's Health. 2010;2:327-337.
45. Hawkins JL. Maternal morbidity and mortality: anaesthetic causes. Can J Anaesth. 2002;49 Suppl 1:R24-R28.
46. Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Semin Perinatol. 2011;35:292-296.
47. Haddad B, Sibai BM. Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol. 2009;33:143-151.
48. Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe pre-eclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011;205:191-198.
49. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206:470-475.
50. Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahodo-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia. Obstet Gynecol. 2011;118:1102-1107.
51. Yancey LM, Withers E, Bakes K, Abbott J. Postpartum preeclampsia: emergency department presentation and management. J Emer Med. 2008;40(4):380-384.
52. Poel YHM, Swinkels P, deVries P. Psychological treatment of women with psychological complaints after pre-eclampsia. J Psychosomatic Obstet Gynecol. 2009; 30(1): 65-72.
53. Klein G. Sources of Power: How People Make Decisions. Cambridge, MA: The MIT Press. 1998.
54. Foy R, Ramsay CR, Grimshaw JM, et al. The impact of guidelines on mild hypertension in pregnancy: time series analysis. BJOG. 2004;111:765-770.
55. von Dadelszen P, Sawchuck D, McMaster R. The active implementation of pregnancy hypertension guidelines in British Columbia. Obstet Gynecol. 2010;116:659-666.